J. Armitage

Publication List Details

Period

1976 - 2007

Number

42

Co-Authors

The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD (2006)

Landray, M., Baigent, C., Leaper, C., Adu, D., Altmann, P., Armitage, J., ...

Background: Evaluating the effects of decreasing low-density lipoprotein (LDL) cholesterol levels requires large randomized trials. In preparation for such a trial, we assessed the biochemical...

Unknown (2001)

Politecnico Federale, Di Losanna, J. Armitage, O. Crochat

this report, please contact Mrs Y. Dubuis, secretary, tel. +41 21 693 52 02 LRC IN-Ecublens 1015 Lausanne - Switzerland crochat@di.epfl.ch tel. +41 21 693 6601 Contents 1

Sourcing mudsprings using integrated paleontological analyses: an example from Wootton Bassett, Wiltshire, England (2000)

Harding, I.C., Armitage, J., Hollingworth, N., Ainsworth, N.

This paper presents comprehensive macro- and micropalaeontological analyses of taxa recovered from mud and stream lags disgorged from mudsprings at Wootton Bassett, Wiltshire, England. These...

A Systems Engineering Capability Maturity Model, Version 1.0. (1998)

Bate, R., Garcia, S., Armitage, J., Cusick, K., Jones, R.

The Systems Engineering Capability Maturity Model (SE-CMM) describes the essential elements of an organization's systems engineering process that must exist to ensure good systems engineering. It...

A Description of the Systems Engineering Capability Maturity Model Appraisal Method Version 1.1. (1998)

Kuhn, D., Wells, C., Armitage, J., Cusick, K., Garcia, S.

The purpose of this document is to summarize the major elements of the Systems Engineering Capability Maturity Model (SE-CMM) appraisal method (SAM). SAM is a method for using the SE-CMM to...

Design of a Survivable WDM Photonic Network (1997)

Armitage, J., Crochat, Olivier, Le Boudec, Jean-Yves

Schemes - Hardware duplication or Mapping algorithm - for protecting a network using a Wavelength Division Multiplexing (WDM) infrastructure against component or link failures.

Design of a Survivable WDM Photonic Network (1996)

Politecnico Federale, Di Losanna, J. Armitage, O. Crochat

We consider schemes for protecting a network using a Wavelength Division Multiplexing (WDM) infrastructure against component or link failures. First, we explain how protection can be achieved by...

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration (1996)

Wardle, J., Armitage, J., Collins, R., Wallendszus, K., Keech, A., Lawson, A.

Objective: To evaluate the effects on mood of a substantial and prolonged reduction in total cholesterol concentration. Design: Randomised placebo controlled comparison of patients who had been...

FORCED VOLUME MAGNETOSTRICTION OF WEAKLY FERROMAGNETIC Y(Co1-xAlx)2 COMPOUNDS (1988)

Riedi, P., Armitage, J., Graham, R., Abell, J.

The forced volume magnetostriction of weakly ferromagnetic Y(Co1-xAlx)2 compounds has been measured to 12 T at 4.2 K and to 5 T at 1.6 K for x near 0.15. Below 9 T the volume magnetostriction is well...

FORCED VOLUME MAGNETOSTRICTION OF WEAKLY FERROMAGNETIC Y(Co1-xAlx)2 COMPOUNDS (1988)

Riedi, P., Armitage, J., Graham, R., Abell, J.

The forced volume magnetostriction of weakly ferromagnetic Y(Co1-xAlx)2 compounds has been measured to 12 T at 4.2 K and to 5 T at 1.6 K for x near 0.15. Below 9 T the volume magnetostriction is well...

FORCED VOLUME MAGNETOSTRICTION OF WEAKLY FERROMAGNETIC Y(Co1-xAlx)2 COMPOUNDS (1988)

Riedi, P., Armitage, J., Graham, R., Abell, J.

The forced volume magnetostriction of weakly ferromagnetic Y(Co1-xAlx)2 compounds has been measured to 12 T at 4.2 K and to 5 T at 1.6 K for x near 0.15. Below 9 T the volume magnetostriction is well...

DISSIPATION IN THE SUPERFLUID FILM BELOW IK (1978)

Armitage, J., Allen, J., Toft, M.

We have measured the transfer rate of the surperfluid helium film at temperatures from 11 mK to 1 K. If the level difference, ∝h, is less than 50 µm the dissipation rises rapidly but more...

DISSIPATION IN THE SUPERFLUID FILM BELOW IK (1978)

Armitage, J., Allen, J., Toft, M.

We have measured the transfer rate of the surperfluid helium film at temperatures from 11 mK to 1 K. If the level difference, ∝h, is less than 50 µm the dissipation rises rapidly but more...

DISSIPATION IN THE SUPERFLUID FILM BELOW IK (1978)

Armitage, J., Allen, J., Toft, M.

We have measured the transfer rate of the surperfluid helium film at temperatures from 11 mK to 1 K. If the level difference, ∝h, is less than 50 µm the dissipation rises rapidly but more...

Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells.

Masih, A., Weisenburger, D., Duggan, M., Armitage, J., Bashir, R., Mitchell, D., ...

A possible etiologic role for Epstein-Barr virus (EBV) in Hodgkin's disease (HD) was investigated by probing for EBV genome in 52 biopsy specimens involved with HD and 43 hyperplastic lymph node...

Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies.

Wu, D P, Gilkeson, G S, Armitage, J, Reich, C F, Pisetsky, D S

To assess the immune recognition of DNA in systemic lupus erythematosus, the antigenic specificity of monoclonal anti-DNA antibodies from autoimmune MRL-lpr/lpr mice was investigated Determinant...

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.

Wardle, J., Armitage, J., Collins, R., Wallendszus, K., Keech, A., Lawson, A.

OBJECTIVE--To evaluate the effects on mood of a substantial and prolonged reduction in total cholesterol concentration. DESIGN--Randomised placebo controlled comparison of patients who had been...

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people

Mihaylova, B., Briggs, A.H., Armitage, J., Parish, S., Gray, A., Collins, R.

Objectives: To evaluate the cost effectiveness of 40 mg simvastatin daily continued for life in people of different ages with differing risks of vascular disease. Design A model developed from a...